Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Diffuse Parenchymal Lung Disease
What immunosuppression regimens do clinicians use in patients with progressive RB-ILD despite smoking cessation and prednisone?
Related Questions
How often do you monitor pulmonary function tests in patients with fibrotic lung disease?
How do you approach pre-operative risk assessment and optimization in a patient with interstitial lung disease?
What is your approach to evaluation and management of GERD in a patient with IPF?
Would you consider adding or switching to pirfenidone for a patient with progressing UIP (based on imaging and PFTs) who is currently on nintedanib?
Would you offer lung SBRT in a patient with Pulmonary Langerhans Cell Histiocytosis (PLCH)?
Have you adopted the use of low dose morphine for treatment of cough in patients with IPF?
What is your approach to managing ILD associated with inflammatory bowel disease?
How long after initiating mycophenolate do you wait before tapering prednisone off in patients with myositis-associated ILD?
What is the duration of steroids that you prescribe for organizing pneumonia?
Would you consider using steroids in patients with respiratory failure caused by aspiration pneumonitis?
